Vitamin C and Vascular Health in Older Adults

Linus Pauling, awarded the 1954 Nobel Prize in Chemistry for his groundbreaking work on the nature of the chemical bond, later became one of the most vocal champions of high‑dose vitamin C. In the early 1990s, he argued that daily intakes ranging from 3 to 18 grams, combined with lysine and proline, could help strengthen blood vessel walls and reduce the binding of lipoprotein(a) — a nutrient‑based strategy he framed as an inexpensive tool for cardiovascular support.

Pauling’s broader message centered on maintaining healthy vasculature, from endothelial function to collagen integrity, and he often pointed to doses well above 6 grams a day. Today, however, the Linus Pauling Institute (LPI) takes a more conservative stance: for general prevention, it recommends roughly 400 milligrams of vitamin C per day, with higher amounts considered in therapeutic contexts.

Vitamin C and Vascular Aging in Older Adults

Drawing on findings from the LPI, endothelial dysfunction — an early and reversible impairment of the blood vessel lining — has emerged as a meaningful marker in the trajectory toward atherosclerosis and cardiovascular disease. Because it can be measured through flow‑mediated dilation, researchers increasingly view improvements in endothelial function as a credible indicator of reduced long‑term risk for heart disease and stroke, particularly in older adults who face heightened oxidative stress, inflammation, and vascular aging.

Key Takeaways for Elders

• Older adults are more likely to have suboptimal vitamin C status (due to lower intakes, absorption changes, or higher needs from oxidative stress), making them more responsive to supplementation.
• The age-specific benefit in the stricter meta-analysis aligns with this: supplementation (500 mg–2 g/day oral) showed clearer improvements in endothelial function in older cohorts.
• Prospective cohort studies link higher vitamin C status (plasma levels) or intakes to lower risks of hypertension, coronary heart disease (CHD), stroke, and heart failure.^[5,9,10] Plasma vitamin C often shows stronger inverse associations than dietary intake alone.
• LPI specifically notes that a vitamin C intake of at least 400 mg/day (from food + supplements) is particularly important for older adults to maintain replete tissue concentrations and protect against oxidative damage linked to chronic diseases like heart disease and stroke.^[1] This exceeds the standard RDA (75–90 mg/day for adults).

Other supportive evidence on the page includes:

• Meta-analyses showing modest blood pressure reductions with supplementation (median ~500 mg/day).
• Inverse associations between higher vitamin C and CHD/stroke risk in observational data.
• Emphasis that older populations (e.g., in studies like EPIC-Norfolk^[5] or Physicians’ Health Study II^[11]) often show these patterns.

Limitations and Balanced Perspective

• Evidence strength — Benefits are most pronounced in older adults or individuals with low vitamin C status, inflammation, or vascular risk factors; healthy, well‑nourished younger adults show little measurable effect.
• As‑needed response — Trials consistently show vitamin C works when the body has a deficit: supplementation improves endothelial function when baseline levels are low, but excess is simply excreted when status is already optimal.
• Trial limitations — Evidence comes largely from short‑ to medium‑term studies on vascular function; long‑term randomized trials on heart attacks or strokes remain limited and yield mixed results.
• Observational confounding — Higher vitamin C intake often tracks with healthier lifestyles, complicating interpretation and underscoring the need for better trials in at‑risk older populations.
• Safety and food-first approach — Supplementation is generally safe up to 2,000 mg/day, but the Linus Pauling Institute emphasizes fruits and vegetables for nutrient synergy and more reliable plasma levels.
• Diet vs supplement evidence — EPIC‑Norfolk (Lancet) shows strong protection tied to diet‑driven plasma vitamin C, while Physicians’ Health Study II (JAMA) found synthetic supplements offered little benefit in already well‑nourished adults.

For older adults, the Institute’s recommendation of at least 400 mg per day — and evidence showing improvements with 500 mg to 2 g per day — suggests a low‑cost, low‑risk strategy that may support vascular health. Still, vitamin C is best viewed as one component of a wider prevention approach built on diet, lifestyle, and addressing deficiencies. Healthcare guidance is essential for anyone considering higher doses or managing kidney‑related concerns.

Vitamin C: How to Take It for Best Effect

These nuances naturally lead to a practical question: if older adults stand to benefit most, how should vitamin C be taken to maximize its impact? Research points to a consistent theme — timing and dosing patterns matter. For higher daily intakes often explored in clinical studies, dividing vitamin C into multiple doses helps maintain steadier plasma levels and reduces the waste associated with single large doses.
Timing can also enhance effectiveness. Studies examining oxidative stress suggest that taking vitamin C near periods of increased strain — such as UV exposure — may help reinforce antioxidant defenses, particularly when paired with complementary antioxidants like vitamin E or consumed within a diet rich in fruits and vegetables. Food remains the foundation for meeting daily needs, with supplements serving as a practical bridge when intake falls short.
Experts underscore that individuals considering high‑dose or therapeutic use should consult a healthcare professional, especially when medical conditions or medications could influence safety or absorption.

Further Inspiration and Resources

1. Linus Pauling Institute. (n.d.). Vitamin C. Oregon State University.
2. Overview of the possible role of vitamin C in management of COVID-19
3. Vitamin C improves gut Bifidobacteria in humans
• Study shows high-dose vitamin C may improve gut bacteria, potentially boost the immune system and fight infections.
4. Ashor, A. W., Siervo, M., Lara, J., Oggioni, C., Afshar, S., & Mathers, J. C. (2015). Effect of vitamin C and vitamin E supplementation on endothelial function: A systematic review and meta-analysis of randomised controlled trials. British Journal of Nutrition, 113(8), 1182–1194. 
5. Khaw, K. T., Bingham, S., Welch, A., Luben, R., Wareham, N., Oakes, S., & Day, N. (2001). Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: A prospective population study. The Lancet, 357(9257), 657–663. 
• Supports plasma vitamin C and lower mortality/CVD risk.)
6. Pfister, R., Sharp, S. J., Luben, R., Khaw, K. T., & Wareham, N. J. (2011). Plasma vitamin C predicts incident heart failure in men and women in European Prospective Investigation into Cancer and Nutrition–Norfolk prospective study. American Heart Journal, 162(2), 246–253. h
7. Sesso, H. D., Buring, J. E., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Glynn, R. J., & Gaziano, J. M. (2008). Vitamins E and C in the prevention of cardiovascular disease in men: The Physicians’ Health Study II randomized controlled trial. JAMA, 300(18), 2123–2133. 
8. Ashor, A. W., Lara, J., Mathers, J. C., & Siervo, M. (2014). Effect of vitamin C on endothelial function in health and disease: A systematic review and meta-analysis of randomised controlled trials. Atherosclerosis, 235(1), 9–20. 
9. Myint, P. K., Luben, R. N., Welch, A. A., Bingham, S. A., Wareham, N. J., & Khaw, K. T. (2008). Plasma vitamin C concentrations predict risk of incident stroke in a population-based cohort study. American Journal of Clinical Nutrition, 87(1), 64–69. 
10. Morelli, M. B., et al. (2020). Vitamin C and cardiovascular disease: An update. Antioxidants, 9(12), 1227. 
11. Violi, F., & Cangemi, R. (2009). Antioxidant supplements and cardiovascular disease in men. JAMA, 301(13), 1335–1337